Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
Understanding the mechanisms driving PI3K isoform dependency in prostate cancer can help the design of future clinical trials. Here, the authors show that gain-of-function mutations in PIK3CA or PIK3CB can confer PI3K p110 isoform dependency and that the direct inhibition of AKT may be superior to P...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/907e2e85e15748fa85c06a824495c169 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|